Novartis Appoints Merck Executive As Research Head
Novartis AG (NYSE: NVS ) has appointed Merck executive Fiona Marshall as president of the Novartis Institutes for Biomedical Research to replace Jay Bradner, who is stepping down after seven years as research head. The company said the appointment of Marshall, currently senior … Full story available on Benzinga.com
Novartis Appoints Merck Executive As Research Head
Novartis AG (NYSE: NVS ) has appointed Merck executive Fiona Marshall as president of the Novartis Institutes for Biomedical Research to replace Jay Bradner, who is stepping down after seven years as research head. The company said the appointment of Marshall, currently senior … Full story available on Benzinga.com